March 2010 references and further reading
HDL: The good, but complex, cholesterol
Barter PJ, Caulfield M, Eriksson M, et al. Effects of torcetrapib in patients at high risk for coronary events [ILLUMINATE trial]. New England Journal of Medicine 2007; 357:2109-22.
Taylor AJ, Villines TC, Stanek EJ, et al. Extended-release niacin or ezetimibe and carotid intima-media thickness. New England Journal of Medicine 2009; 361:2113-22.
Bringing clarity to CRP testing
Genest J, McPherson R, Frohlich J, et al. 2009 Canadian Cardiovascular Society/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult - 2009 recommendations. Canadian Journal of Cardiology 2009; 25:567-79.